Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
Phase III Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer
This trial compares the use of 6 fractions versus the standard 5 fractions of radiotherapy used in the treatment of head and neck cancer.
The purpose of this trial is to study the clinical effects of increasing the weekly fraction number for locally advanced head and neck cancers by a multi-institutional prospective randomised trial. The primary endpoint is to clarify whether a six fraction per week protocol has a greater effect on the survival, as compared to the conventional five fraction per week protocol.
Inclusion Criteria:
Exclusion Criteria: